Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
about
Atypical antipsychotics in Parkinson-sensitive populations.Rationale for current therapies in Parkinson's disease.The serotonergic system in motor and non-motor manifestations of Parkinson's disease.Treating psychosis in movement disorder patients: a review.Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease.
P2860
Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@ast
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@en
type
label
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@ast
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@en
prefLabel
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@ast
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@en
P2093
P2860
P356
P1433
P1476
Suppression of dyskinesias in ...... ong-term dyskinesia reduction.
@en
P2093
Bennett JP Jr
Dietrich S
P2860
P304
P356
10.1002/MDS.870090406
P407
P577
1994-07-01T00:00:00Z